Home / SMDPY : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SMDPY make money? Does SMDPY have pricing power? What's the Earnings Whisper? Will SMDPY profit more as the business scales? What is SMDPY's management track record? Is SMDPY's current price justified?

Sumitomo Pharma Co., Ltd.

$10.45 -$1.00 (-8.73%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$10.45

Day Range

$10.45$11

Year Range

$7.84$24.48

Market Cap

4.69B

AVG Volume

933

Trailing/Forward PE

5.52/-

PEG ratio

2.09

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (JPY) · TTM

SMDPY Revenue (JPY) · TTM by quarter
Period	Revenue (JPY) · TTM
27 Q1	480.98B
26 Q4	459.49B
26 Q3	457.65B
26 Q2	447.28B
26 Q1	416.16B
25 Q4	398.83B
25 Q3	372.71B
25 Q2	342.67B
25 Q1	329.55B
24 Q4	314.56B

Net Income (JPY) · TTM

SMDPY Net Income (JPY) · TTM by quarter
Period	Net Income (JPY) · TTM
27 Q1	114.33B
26 Q4	108.54B
26 Q3	111.78B
26 Q2	156.25B
26 Q1	18.9B
25 Q4	23.63B
25 Q3	-176.04B
25 Q2	-279.46B
25 Q1	-260.17B
24 Q4	-314.96B

Operating Income (JPY) · TTM

SMDPY Operating Income (JPY) · TTM by quarter
Period	Operating Income (JPY) · TTM
27 Q1	49B
26 Q4	51.21B
26 Q3	71.78B
26 Q2	81.07B
26 Q1	52.29B
25 Q4	28.79B
25 Q3	-223.9B
25 Q2	-276.56B
25 Q1	-306.4B
24 Q4	-354.86B

EBITDA (JPY) · TTM

SMDPY EBITDA (JPY) · TTM by quarter
Period	EBITDA (JPY) · TTM
27 Q1	129.93B
26 Q4	133.52B
26 Q3	139.03B
26 Q2	146.97B
26 Q1	39.9B
25 Q4	39.79B
25 Q3	-172.69B
25 Q2	-221.81B
25 Q1	-217.17B
24 Q4	-264.34B

Cash Flows (JPY) · TTM

SMDPY Cash Flows (JPY) · TTM by quarter
Period	Cash Flows (JPY) · TTM
27 Q1	63.03B
26 Q4	69.47B
26 Q3	48.82B
26 Q2	23.61B
26 Q1	33.69B
25 Q4	8B
25 Q3	-16.63B
25 Q2	-74.2B
25 Q1	-150.54B
24 Q4	-257.62B

EPS (JPY) · TTM

SMDPY EPS (JPY) · TTM by quarter
Period	EPS (JPY) · TTM
27 Q1	284.53
26 Q4	273.72
26 Q3	281.88
26 Q2	393.82
26 Q1	47.58
25 Q4	59.48
25 Q3	-443.12
25 Q2	-703.42
25 Q1	-654.86
24 Q4	-792.78

Expenses (JPY) · TTM

SMDPY Expenses (JPY) · TTM by quarter
Period	Expenses (JPY) · TTM
27 Q1	220.12B
26 Q4	214.1B
26 Q3	218.15B
26 Q2	216.15B
26 Q1	223.49B
25 Q4	238.97B
25 Q3	423.88B
25 Q2	453.57B
25 Q1	479.85B
24 Q4	526.07B

Dividends (JPY)

SMDPY Dividends (JPY) by quarter
Period	Dividends (JPY)
Mar 23	0.03

PE Ratio

SMDPY PE Ratio by quarter
Period	PE Ratio
Sep 26	5.9
Sep 26	6.3
Aug 26	5.46
Aug 26	5.5
Aug 26	5.22
Aug 26	4.64
Jul 26	4.53
Jul 26	5.56
Jul 26	5.51
Jul 26	5.48
Jul 26	5.47
Jun 26	5.32
Jun 26	5.31
Jun 26	5.15
Jun 26	5.57
May 26	5.53
May 26	6.18
May 26	6.17
May 26	5.75
May 26	6.28
Apr 26	6.65
Apr 26	6.62
Apr 26	6.65
Apr 26	8.13
Mar 26	4.95
Mar 26	4.91
Mar 26	4.93
Mar 26	4.99
Feb 26	6.08
Feb 26	7.17
Feb 26	5.72
Feb 26	5.89
Jan 26	4.51
Jan 26	4.53
Jan 26	4.6
Jan 26	4.6
Jan 26	4.57
Dec 25	37.66
Dec 25	37.95
Dec 25	37.49
Dec 25	37.38
Nov 25	37.57
Nov 25	37.62
Nov 25	37.18
Nov 25	36.92
Oct 25	37.06
Oct 25	36.79
Oct 25	36.25
Oct 25	34.94
Oct 25	34.09
Sep 25	27.64
Sep 25	27.36
Sep 25	24.82
Sep 25	24.77
Aug 25	24.72
Aug 25	24.69
Aug 25	24.73
Aug 25	23.09
Aug 25	18.98
Jul 25	19.29
Jul 25	19.43
Jul 25	18.06
Jul 25	14.81
Mar 23	26.54
Mar 23	26.77
Mar 23	27.42
Mar 23	27.57
Feb 23	32.8
Feb 23	32.24
Feb 23	31.58
Feb 23	31.52
Jan 23	31.18
Jan 23	31.13
Jan 23	30.72
Jan 23	31.75
Dec 22	31.51
Dec 22	4.89
Dec 22	5.3
Dec 22	5.29
Dec 22	5.21
Nov 22	5.39
Nov 22	5.44

Free Cash Flow Yield

SMDPY Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	10.85%
Sep 26	10.16%
Aug 26	11.72%
Aug 26	11.63%
Aug 26	12.27%
Aug 26	13.79%
Jul 26	14.14%
Jul 26	11.52%
Jul 26	11.62%
Jul 26	11.67%
Jul 26	11.71%
Jun 26	8.22%
Jun 26	8.23%
Jun 26	8.48%
Jun 26	7.84%
May 26	7.89%
May 26	7.06%
May 26	7.08%
May 26	7.6%
May 26	6.96%
Apr 26	6.57%
Apr 26	6.59%
Apr 26	6.57%
Apr 26	5.37%
Mar 26	3.05%
Mar 26	3.07%
Mar 26	3.07%
Mar 26	3.03%
Feb 26	2.48%
Feb 26	2.11%
Feb 26	2.64%
Feb 26	2.56%
Jan 26	3.35%
Jan 26	3.33%
Jan 26	3.28%
Jan 26	3.29%
Jan 26	3.31%
Dec 25	4.73%
Dec 25	4.7%
Dec 25	4.75%
Dec 25	4.77%
Nov 25	4.74%
Nov 25	4.74%
Nov 25	4.79%
Nov 25	4.83%
Oct 25	4.81%
Oct 25	4.85%
Oct 25	4.92%
Oct 25	5.1%
Oct 25	5.23%
Sep 25	1.23%
Sep 25	1.24%
Sep 25	1.36%
Sep 25	1.37%
Aug 25	1.37%
Aug 25	1.37%
Aug 25	1.37%
Aug 25	1.47%
Aug 25	1.78%
Jul 25	1.76%
Jul 25	1.74%
Jul 25	1.87%
Jul 25	2.29%
Jun 25	-4.76%
Jun 25	-4.71%
Jun 25	-4.78%
Jun 25	-6.05%
May 25	-6.08%
May 25	-6.14%
Feb 25	-27.73%
Feb 25	-27.69%
Feb 25	-27.85%
Jan 25	-29.36%
Jan 25	-29.21%
Jan 25	-29.15%
Jan 25	-28.89%
Jan 25	-28.97%
Dec 24	-58.57%
Dec 24	-59.11%
Dec 24	-60.18%
Dec 24	-61.63%
Nov 24	-61.73%
Nov 24	-59.74%
Nov 24	-59.9%
Nov 24	-60.58%
Nov 24	-56.7%
Oct 24	-56.96%
Oct 24	-58.02%
Oct 24	-59.95%
Oct 24	-60.12%
Sep 24	-104.38%
Sep 24	-226.53%
Sep 24	-231.47%
Sep 24	-229.1%
May 24	-232.31%
May 24	-233.3%
May 24	-199.56%
Apr 24	-188.55%
Apr 24	-182.3%
Mar 24	-132.88%

Price to Sales

SMDPY Price to Sales by quarter
Period	Price to Sales
Sep 26	1.39
Sep 26	1.49
Aug 26	1.29
Aug 26	1.3
Aug 26	1.23
Aug 26	1.1
Jul 26	1.07
Jul 26	1.31
Jul 26	1.3
Jul 26	1.3
Jul 26	1.29
Jun 26	1.3
Jun 26	1.3
Jun 26	1.26
Jun 26	1.36
May 26	1.35
May 26	1.51
May 26	1.51
May 26	1.4
May 26	1.53
Apr 26	1.62
Apr 26	1.62
Apr 26	1.62
Apr 26	1.99
Mar 26	1.73
Mar 26	1.72
Mar 26	1.72
Mar 26	1.74
Feb 26	2.13
Feb 26	2.51
Feb 26	2
Feb 26	2.06
Jan 26	1.57
Jan 26	1.58
Jan 26	1.61
Jan 26	1.61
Jan 26	1.59
Dec 25	1.71
Dec 25	1.72
Dec 25	1.7
Dec 25	1.7
Nov 25	1.71
Nov 25	1.71
Nov 25	1.69
Nov 25	1.68
Oct 25	1.68
Oct 25	1.67
Oct 25	1.65
Oct 25	1.59
Oct 25	1.55
Sep 25	1.64
Sep 25	1.62
Sep 25	1.47
Sep 25	1.47
Aug 25	1.46
Aug 25	1.46
Aug 25	1.47
Aug 25	1.37
Aug 25	1.12
Jul 25	1.14
Jul 25	1.15
Jul 25	1.07
Jul 25	0.88
Jun 25	0.94
Jun 25	0.95
Jun 25	0.93
Jun 25	0.74
May 25	0.73
May 25	0.73
Feb 25	0.78
Feb 25	0.78
Feb 25	0.78
Jan 25	0.74
Jan 25	0.74
Jan 25	0.74
Jan 25	0.75
Jan 25	0.75
Dec 24	0.78
Dec 24	0.77
Dec 24	0.76
Dec 24	0.74
Nov 24	0.74
Nov 24	0.76
Nov 24	0.76
Nov 24	0.75
Nov 24	0.81
Oct 24	0.8
Oct 24	0.79
Oct 24	0.76
Oct 24	0.76
Sep 24	0.78
Sep 24	0.36
Sep 24	0.35
Sep 24	0.36
May 24	0.38
May 24	0.38
May 24	0.44
Apr 24	0.46
Apr 24	0.48
Mar 24	0.4

EV/EBITDA

SMDPY EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	6.1
Sep 26	6.42
Aug 26	5.74
Aug 26	5.77
Aug 26	5.54
Aug 26	5.07
Jul 26	4.98
Jul 26	5.82
Jul 26	5.78
Jul 26	5.76
Jul 26	5.74
Jun 26	5.72
Jun 26	5.72
Jun 26	5.59
Jun 26	5.93
May 26	5.9
May 26	6.42
May 26	6.41
May 26	6.07
May 26	6.5
Apr 26	6.8
Apr 26	6.78
Apr 26	6.8
Apr 26	7.99
Mar 26	6.81
Mar 26	6.78
Mar 26	6.79
Mar 26	6.86
Feb 26	8.02
Feb 26	9.18
Feb 26	7.64
Feb 26	7.82
Jan 26	6.34
Jan 26	6.37
Jan 26	6.44
Jan 26	6.44
Jan 26	6.4
Dec 25	25.08
Dec 25	25.22
Dec 25	25
Dec 25	24.95
Nov 25	25.04
Nov 25	25.06
Nov 25	24.86
Nov 25	24.73
Oct 25	24.8
Oct 25	24.67
Oct 25	24.41
Oct 25	23.79
Oct 25	23.39
Sep 25	23.09
Sep 25	22.92
Sep 25	21.41
Sep 25	21.38
Aug 25	21.35
Aug 25	21.34
Aug 25	21.36
Aug 25	20.39
Aug 25	17.94
Jul 25	18.13
Jul 25	18.21
Jul 25	17.4
Jul 25	15.47
Sep 23	14.58
Sep 23	14.71
Sep 23	13.81
Sep 23	13.75
Aug 23	13.75
Aug 23	13.71
Aug 23	21.19
May 23	3.23
May 23	3.21
May 23	3.15
May 23	3.13
Apr 23	3.17
Apr 23	3.25
Apr 23	3.24
Apr 23	3.19
Mar 23	3.21
Mar 23	3.08
Mar 23	3.11
Mar 23	3.19
Mar 23	3.21
Feb 23	3.87
Feb 23	3.8
Feb 23	3.72
Feb 23	3.71
Jan 23	3.67
Jan 23	3.66
Jan 23	3.61
Jan 23	3.74
Dec 22	3.71
Dec 22	2.45
Dec 22	2.66
Dec 22	2.65
Dec 22	2.61
Nov 22	2.7
Nov 22	2.73

Price/Operating Cashflow

SMDPY Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	8.62
Sep 26	9.21
Aug 26	7.98
Aug 26	8.04
Aug 26	7.62
Aug 26	6.78
Jul 26	6.62
Jul 26	8.12
Jul 26	8.05
Jul 26	8.01
Jul 26	7.99
Jun 26	10.75
Jun 26	10.73
Jun 26	10.42
Jun 26	11.27
May 26	11.2
May 26	12.51
May 26	12.47
May 26	11.62
May 26	12.7
Apr 26	13.46
Apr 26	13.4
Apr 26	13.45
Apr 26	16.45
Mar 26	25.11
Mar 26	24.94
Mar 26	25.02
Mar 26	25.33
Feb 26	30.88
Feb 26	36.41
Feb 26	29.05
Feb 26	29.92
Jan 26	22.87
Jan 26	23.01
Jan 26	23.36
Jan 26	23.34
Jan 26	23.17
Dec 25	17.13
Dec 25	17.26
Dec 25	17.06
Dec 25	17.01
Nov 25	17.09
Nov 25	17.11
Nov 25	16.92
Nov 25	16.8
Oct 25	16.86
Oct 25	16.74
Oct 25	16.49
Oct 25	15.89
Oct 25	15.51
Sep 25	39.59
Sep 25	39.19
Sep 25	35.55
Sep 25	35.48
Aug 25	35.4
Aug 25	35.37
Aug 25	35.42
Aug 25	33.07
Aug 25	27.18
Jul 25	27.62
Jul 25	27.84
Jul 25	25.87
Jul 25	21.21
Sep 23	15.9
Sep 23	16.19
Sep 23	14.26
Sep 23	14.12
Aug 23	14.13
Aug 23	14.03
Aug 23	30.05
May 23	4.36
May 23	4.34
May 23	4.27
May 23	4.24
Apr 23	4.29
Apr 23	4.39
Apr 23	4.37
Apr 23	4.31
Mar 23	4.34
Mar 23	3.78
Mar 23	3.82
Mar 23	3.91
Mar 23	3.93
Feb 23	4.68
Feb 23	4.6
Feb 23	4.5
Feb 23	4.49
Jan 23	4.45
Jan 23	4.44
Jan 23	4.38
Jan 23	4.53
Dec 22	4.49
Dec 22	5.24
Dec 22	5.67
Dec 22	5.67
Dec 22	5.58
Nov 22	5.78
Nov 22	5.83

Price to Book

SMDPY Price to Book by quarter
Period	Price to Book
Sep 26	2.18
Sep 26	2.33
Aug 26	2.02
Aug 26	2.03
Aug 26	1.93
Aug 26	1.71
Jul 26	1.67
Jul 26	2.05
Jul 26	2.04
Jul 26	2.03
Jul 26	2.02
Jun 26	2.06
Jun 26	2.05
Jun 26	1.99
Jun 26	2.15
May 26	2.14
May 26	2.39
May 26	2.38
May 26	2.22
May 26	2.43
Apr 26	2.57
Apr 26	2.56
Apr 26	2.57
Apr 26	3.14
Mar 26	2.86
Mar 26	2.85
Mar 26	2.85
Mar 26	2.89
Feb 26	3.52
Feb 26	4.15
Feb 26	3.31
Feb 26	3.41
Jan 26	2.61
Jan 26	2.63
Jan 26	2.66
Jan 26	2.66
Jan 26	2.64
Dec 25	4.04
Dec 25	4.07
Dec 25	4.02
Dec 25	4.01
Nov 25	4.03
Nov 25	4.04
Nov 25	3.99
Nov 25	3.96
Oct 25	3.98
Oct 25	3.95
Oct 25	3.89
Oct 25	3.75
Oct 25	3.66
Sep 25	3.85
Sep 25	3.82
Sep 25	3.46
Sep 25	3.45
Aug 25	3.45
Aug 25	3.44
Aug 25	3.45
Aug 25	3.22
Aug 25	2.65
Jul 25	2.69
Jul 25	2.71
Jul 25	2.52
Jul 25	2.07
Jun 25	2.1
Jun 25	2.12
Jun 25	2.1
Jun 25	1.66
May 25	1.65
May 25	1.63
Feb 25	2.34
Feb 25	2.35
Feb 25	2.33
Jan 25	2.21
Jan 25	2.22
Jan 25	2.23
Jan 25	2.25
Jan 25	2.24
Dec 24	1.6
Dec 24	1.58
Dec 24	1.55
Dec 24	1.52
Nov 24	1.52
Nov 24	1.57
Nov 24	1.56
Nov 24	1.54
Nov 24	1.65
Oct 24	1.64
Oct 24	1.61
Oct 24	1.56
Oct 24	1.56
Sep 24	1.58
Sep 24	0.73
Sep 24	0.71
Sep 24	0.72
May 24	0.36
May 24	0.36
May 24	0.42
Apr 24	0.45
Apr 24	0.46
Mar 24	0.38

No video analysis for this stock yet. Request one from our team.

News: SMDPY

businesswire.com · 12 Aug 2026

Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sumitomo Pharma America, Inc. (SMPA) today announced that the first patient in its study evaluating DSP-3077 in the treatment of non-syndromic retinitis pigmentosa (RP) has undergone subretinal implantation. DSP-3077 is an investigative regenerative cell therapy that leverages allogeneic retinal sheets derived from induced pluripotent stem (iPS) cells. This Phase 1/2a, open-label, single-arm, uncontrolled, dose-escalation study (NCT06891885) is evaluating tw.

AI Analysis

Sumitomo Pharma Co., Ltd.

Video analysis: SMDPY

News: SMDPY

Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa

Similar companies